How does ORGO's earnings trend compare year-over-year?

Organogenesis (ORGO) has demonstrated significant year-over-year growth in its net income, although there have been fluctuations. Here's a comparison of ORGO's net income trend over the past few years:

1. **Growth from 2020 to 2021**: ORGO's net income increased from $17.23 million in 2020 to $94.2 million in 2021, showing a substantial rise of $76.97 million.
2. **Decline from 2021 to 2022**: After the significant growth in 2021, ORGO's net income decreased by $78.67 million, from $94.2 million to $15.53 million.
3. **Stabilization from 2022 to 2023**: There was a slight increase of $0.42 million in ORGO's net income, from $15.53 million to $16.95 million. However, this was followed by a decrease of $87.25 million, to $4.95 million, in 2024.
4. **Recent Performance**: The most recent data shows a substantial drop in net income, with ORGO reporting $861,000 for 2024Q4 compared to $4.95 million for 2023Q4, a decrease of $4.09 million.

|code|Ticker|Name|Date|Net Income (FY) YoY|Net Income (FY)|market_code|
|---|---|---|---|---|---|---|
|ORGO|ORGO.O|Organogenesis|2020|144.52194580071819|1.7234E7|186|
|ORGO|ORGO.O|Organogenesis|2021|446.6055471741906|9.4202E7|186|
|ORGO|ORGO.O|Organogenesis|2022|-83.5120273454916|1.5532E7|186|
|ORGO|ORGO.O|Organogenesis|2023|-68.16250321916044|4945000|186|
|ORGO|ORGO.O|Organogenesis|2024|-82.58847320525784|861000|186|

The trend analysis indicates that ORGO has experienced a significant decline in net income from 2022 to 2023, with a slight stabilization in 2023 but a substantial decrease in 2024. The recent performance suggests that ORGO's net income is under pressure, and the company may face challenges in the near term.